S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.46 CNY -0.76%
Market Cap: 35.1B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shenzhen Salubris Pharmaceuticals Co Ltd

Wall Street analysts forecast Shenzhen Salubris Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Salubris Pharmaceuticals Co Ltd is 37.74 CNY with a low forecast of 33.33 CNY and a high forecast of 43.05 CNY.

Lowest
Price Target
33.33 CNY
6% Upside
Average
Price Target
37.74 CNY
20% Upside
Highest
Price Target
43.05 CNY
37% Upside
Shenzhen Salubris Pharmaceuticals Co Ltd Competitors:
Price Targets
600085
Beijing Tongrentang Co Ltd
17% Upside
300363
Porton Pharma Solutions Ltd
21% Upside
326030
SK Biopharmaceuticals Co Ltd
9% Upside
DPHARMA
Duopharma Biotech Bhd
21% Upside
1795
Lotus Pharmaceutical Co Ltd
58% Upside
ARVN
Arvinas Inc
165% Upside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
69% Upside

Revenue
Forecast

Revenue Estimate
Shenzhen Salubris Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Salubris Pharmaceuticals Co Ltd's revenue is 0%. The projected CAGR for the next 3 years is 18%.

0%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Shenzhen Salubris Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Salubris Pharmaceuticals Co Ltd's operating income is -10%. The projected CAGR for the next 3 years is 17%.

-10%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shenzhen Salubris Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Salubris Pharmaceuticals Co Ltd's net income is -9%. The projected CAGR for the next 3 years is 15%.

-9%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's stock price target?
Price Target
37.74 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Salubris Pharmaceuticals Co Ltd is 37.74 CNY with a low forecast of 33.33 CNY and a high forecast of 43.05 CNY.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Shenzhen Salubris Pharmaceuticals Co Ltd's revenue is 0%. The projected CAGR for the next 3 years is 18%.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Shenzhen Salubris Pharmaceuticals Co Ltd's operating income is -10%. The projected CAGR for the next 3 years is 17%.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Shenzhen Salubris Pharmaceuticals Co Ltd's net income is -9%. The projected CAGR for the next 3 years is 15%.

Back to Top